CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 7,000 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001823
NCT00001823N/ARecruitingOn Track
Long Recruiting
CompareCT.gov

Evaluation for NCI Surgery Branch Clinical Research Protocols

National Cancer Institute (NCI)·observational·Posted Nov 4, 1999·Updated Jun 11, 2026

In Brief

An observational study for Synovial Cell Cancer and 4 related conditions. Currently recruiting, targeting 7,000 participants across 1 site.

Detailed Summary

Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSynovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer
CountriesUnited States
Collaborators--

Timeline

N/ARecruiting
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartJul 11, 1999
TodayJul 1, 2026
Posted 26.7 years ago

Arms & Interventions

A/Surgery Branch Protocol Candidatesother

Patients suspected of having, or with biopsy proven, malignant disease being evaluated for or treated on NCI Surgery Branch protocols